Zhejiang Ausun Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 429.68 million compared to CNY 301.87 million a year ago. Revenue was CNY 429.68 million compared to CNY 301.87 million a year ago.

Net income was CNY 110.31 million compared to CNY 66.19 million a year ago. Basic earnings per share from continuing operations was CNY 0.2714 compared to CNY 0.1714 a year ago. Diluted earnings per share from continuing operations was CNY 0.2714 compared to CNY 0.1714 a year ago.